OVERVIEW OF SYSTEMIC LUPUS ERYTHEMATOSUS RISK FACTORS AND RELATED COMPLICATIONS
Main Article Content
Keywords
Systemic lupus erythematosus (SLE), Etiology, Pathophysiology, Flare, Complications
Abstract
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease where the immune system attacks the body's cells and tissues, causing inflammation and tissue damage. SLE presents clinically in a diverse manner, impacting various organs such as the heart, joints, skin, lungs, kidneys, and nervous system. The production of autoantibodies, especially antinuclear and anti-DNA antibodies, is linked to SLE and its symptoms may vary among patients, with common signs including rash, arthritis, and fatigue. The disease's development involves genetic, epigenetic, and environmental elements, influencing abnormal B- and T-cell activity.
References
2. Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modeling study. 2023;82(3):351-6.
3. Salem R, Al-Mansouri SJGJoHS. The Prevalence of Dry Eye Syndrome in Systemic Lupus Erythematosus Patients in Saudi Arabia. 2023;15(7):11-8.
4. Izmirly PM, Parton H, Wang L, McCune WJ, Lim SS, Drenkard C, et al. Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus Registries. 2021;73(6):991-6.
5. Bohuliga KG, Alhawsa B, Omair MA, Alqurtas E, Bdewi M, Alqarawi W, et al. AB0639 PREVALENCE OF MACE AMONG SAUDI WITH SLE. 2023;82(Suppl 1):1522-.
6. AlOmair M, AlMalki H, AlShahrani M, Mushait H, Al Qout M, Alshehri T, et al. Clinical Manifestations of Systemic Lupus Erythematosus in a Tertiary Center in Saudi Arabia. Cureus. 2023;15(6):e41215.
7. Taheri M, Eghtedarian R, Dinger ME, Ghafouri-Fard S. Exploring the Role of Non-Coding RNAs in the Pathophysiology of Systemic Lupus Erythematosus. 2020;10(6):937.
8. Caielli S, Wan Z, Pascual V. Systemic Lupus Erythematosus Pathogenesis: Interferon and Beyond. 2023;41(Volume 41, 2023):533-60.
9. Shuoshan X, Changjuan X, Honglin Z, Qinghua Z, Shaxi O, Qi W, et al. Genetic variants related to systemic lupus erythematosus revealed using bioinformatics. 2022;20:20587392211070407.
10. Rezaieyazdi Z, Nomani H, Hatef MR, Afshari JT, Abbasi M, Esmaily H, et al. Correlations and influence of TAP2 genes polymorphisms and systemic lupus erythematosus propensity. 2021;17(4):404-11.
11. Elkon KB, Lood C. 8 - The Innate Immune System in SLE. In: Wallace DJ, Hahn BH, editors. Dubois' Lupus Erythematosus and Related Syndromes (Ninth Edition). London: Elsevier; 2019. p. 93-100.
12. Ogedegbe OJ, Okun O, Erebo JK, Augustine OB, Chukwuka E, Udegbe DC, et al. Cardiovascular Manifestations of Systemic Lupus Erythematosus: An Overview.
13. Elkon KB, Wiedeman A. Type I IFN system in the development and manifestations of SLE. 2012;24(5):499-505.
14. Panikkath DR, Sandhu VK. Cutaneous Manifestations of Systemic Lupus Erythematosus. 2022;14(4):163-9.
15. Afrashteh Nour M, Ghorbaninezhad F, Asadzadeh Z, Baghbanzadeh A, Hassanian H, Leone P, et al. The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis. 2023;14:20406223231153572.
16202MENT ACTIVITY SPECIFICALLY THOUGH THE LECTIN -OR THE CLASSICAL PATHWAY IN PATIENTS WITH SLE. 2022;81(Suppl 1):246-.
18. Li NL, Birmingham DJ, Rovin BH. Expanding the Role of Complement Therapies: The Case for Lupus Nephritis. 2021;10(4):626.
19. Refai RH, Hussein MF, Abdou MH, Abou-Raya AN. Environmental risk factors of systemic lupus erythematosus: a case-control study. Scientific reports. 2023;13(1):10219.
20. Wolf SJ, Estadt SN, Gudjonsson JE, Kahlenberg JMJFii. Human and murine evidence for mechanisms driving autoimmune photosensitivity. 2018;9:415481.
21. Joo YB, Kim K-J, Park K-S, Park Y-JJSR. Influenza infection as a trigger for systemic lupus erythematosus flares resulting in hospitalization. 2021;11(1):4630.
22. Liaqat A, Barlas A, Barlas T, Khurram H, Liaqat HJC. Ciprofloxacin-Induced Reaction Imitating a Lupus Flare: A Case Report. 2020;12(5).
23. Touil H, Mounts K, De Jager PLJFii. Differential impact of environmental factors on systemic and localized autoimmunity. 2023;14:1147447.
24. García BEC, Pesántez DCM, Cabrera JJO, Martínez MÁV, Ordónez BAM, Rivera FDP, et al. BRIEF REVIEW ABOUT NEUROLOGICAL, HEMATOLOGICAL, GASTROINTESTINAL, CARDIOVASCULAR AND PULMONAR MANIFESTATIONS OF SYSTEMIC ERYTHEMATOSUS LUPUS. 2023;9(1):161-4.
25. Hafeez MH, Safdar W, Arshad A, Talpur F, Ali Y, Mustafa S, et al. Systemic Lupus Erythematosus and its major organ complications: a narrative review on available literature. 2023;5:1-10.
26. Kedia N, Theillac V, Paez-Escamilla M, Indermill C, Gallagher DS, Adam R, et al. The full range of ophthalmological clinical manifestations in systemic lupus erythematosus. 2023;2.
27. Stolyar L, Rizi B, Lin S, Hsieh E. Systemic lupus erythematosus presenting as Evans syndrome. 2019;7(12):2513-4.
28. Hannah JR, D'Cruz DP, editors. Pulmonary complications of systemic lupus erythematosus. Seminars in respiratory and critical care medicine; 2019: Thieme Medical Publishers.
29. Koarada S. Systemic Lupus Erythematosus: A Systematic Approach to Arthritis of Rheumatic Diseases: Volume 4: Bentham Science Publishers; 2022.